A new class of nipecotic acid and guvacine derivatives has been synthesized and characterized for their inhibitory potency at mGAT1–4 and binding affinity for mGAT1. Compounds of the described class are defined by a four‐carbon‐atom allenyl spacer connecting the nitrogen atom of the nipecotic acid or guvacine head with an aromatic residue. Among the compounds investigated, the mixture of nipecotic acid derivatives rac‐{(Ra)‐1‐[4‐([1,1′:2′,1′′‐terphenyl]‐2‐yl)buta‐2,3‐dien‐1‐yl](3R)‐piperidine‐3‐carboxylic acid} and rac‐{(Sa)‐1‐[4‐([1,1′:2′,1′′‐terphenyl]‐2‐yl)buta‐2,3‐dien‐1‐yl](3R)‐piperidine‐3‐carboxylic acid} (21 p), possessing an o‐terphenyl residue, was identified as highly selective and the most potent mGAT1 inhibitor in this study. For the (R)‐nipecotic acid derived form of 21 p, the inhibitory potency in [3H]GABA uptake assays was determined as pIC50=6.78±0.08, and the binding affinity in MS Binding Assays as pKi=7.10±0.12. The synthesis of the designed compounds was carried out by a two‐step procedure, generating the allene moiety via allenylation of terminal alkynes which allows broad variation of the terminal phenyl and biphenyl subunit.